I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 8 studies | 27% ± 14% | |
| B cell | 7 studies | 21% ± 6% | |
| natural killer cell | 6 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 40% ± 15% | |
| oligodendrocyte | 4 studies | 20% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 0% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 1% | |
| hematopoietic precursor cell | 3 studies | 25% ± 12% | |
| non-classical monocyte | 3 studies | 24% ± 6% | |
| naive B cell | 3 studies | 17% ± 2% | |
| retinal bipolar neuron | 3 studies | 27% ± 8% | |
| endothelial cell | 3 studies | 28% ± 5% | |
| goblet cell | 3 studies | 24% ± 9% | |
| basal cell | 3 studies | 35% ± 15% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 4% | |
| astrocyte | 3 studies | 25% ± 3% |
